Filter Stories By
OR
Cancer
Late-Stage Melanoma: Experimental Drug Combo Puts 50% of Patients Into Remission
Melanoma is a kind of skin cancer. While it has a 99% survival rate in its early stages, stage IV melanoma — when cancer has spread to organs such as the lungs — has a survival rate of 30%. Drugs known as immune checkpoint inhibitors (ICI) have improved the outlook for many people with melanoma. ICIs prevent … Read More
Published On: January 3, 2023
Hoag Launches Phase 1 Study That May Change the Face of Cancer Treatment
Hoag Memorial Hospital Presbyterian in Newport Beach, Orange County, California, will be the first in Southern California (and only one of a handful of trial sites worldwide) to launch a Phase 1 clinical trial to test the efficacy of a new cancer treatment that may change the face of cancer treatment. Led by Dr. Gary … Read More
Published On: December 20, 2022
Hoag Recruits Top Cancer Research Medical Director
NEWPORT BEACH, Calif., November 15, 2022 — Hoag Memorial Hospital Presbyterian has recruited top cancer researcher Carlos Becerra, M.D., to become the Hoag Family Cancer Institute’s Medical Director of Cancer Research. He will provide strategic leadership in advancing the institute’s clinical research program and helm the hospital’s growing number of cancer clinical trials. Dr. Becerra … Read More
Published On: November 15, 2022
Hoag Named Radiopharmaceutical Therapy Center of Excellence, Publishes Results of Breast and Prostate Cancer Trials
NEWPORT BEACH, Calif. (September 7, 2022) – Hoag Memorial Hospital Presbyterian has been named a Radiopharmaceutical Therapy Center of Excellence (RTCoE) by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a distinction held by only 17 centers in the U.S., including Stanford Health Care, Harvard Medical School and the University of California, San Francisco. … Read More
Published On: September 7, 2022
Renowned Dermatologist and Mohs Surgeon Joins Hoag
NEWPORT BEACH, Calif., August 16, 2022 — Hoag Memorial Hospital Presbyterian is proud to announce that Steven Wang, M.D., a renowned, board-certified dermatologist and fellowship-trained Mohs surgeon, has joined the Hoag Family Cancer Institute as the Director of Dermatologic Oncology as part of the Melanoma Program. Dr. Wang joins Hoag after spending 16 years at … Read More
Published On: August 16, 2022
First FDA-Approved Molecular Targeted Therapy for Metastatic Prostate Cancer Now Available at Hoag Family Cancer Institute
NEWPORT BEACH, Calif., March 29, 2022 — Hoag Memorial Hospital Presbyterian welcomed last week’s announcement by the U.S. Food & Drug Administration that the FDA approved the first prostate specific membrane antigen (PSMA)-targeted radiotherapy for metastatic prostate cancer. The agent, lutetium Lu 177 vipivotide tetraxetan (Pluvicto), delivers radiation directly to prostate cancer cells and has … Read More
Published On: March 29, 2022
Hoag Selects Accomplished Oncologist as Director of Hoag Melanoma Program
NEWPORT BEACH, Calif., Feb. 23, 2022 — Hoag Memorial Hospital Presbyterian announced today that Thomas N. Wang, M.D., Ph.D., F.A.C.S., a prominent researcher and nationally recognized author, has been named medical director of the Hoag Melanoma/Advanced Skin Cancer Program. Dr. Wang comes to Hoag after spending the previous 15 years at the University of Alabama … Read More
Published On: February 14, 2022
Hoag Physician Named President of the American College of Nuclear Medicine
NEWPORT BEACH, Calif., January 27, 2022 – Hoag Memorial Hospital Presbyterian announced today that the American College of Nuclear Medicine (ACNM) has elected Gary Ulaner, M.D., Ph.D., F.A.C.N.M., James & Pamela Muzzy Endowed Chair in Molecular Imaging and Therapy and director of Molecular Imaging and Therapy for the Hoag Family Cancer Institute, as its 2022-2023 … Read More
Published On: January 27, 2022
Nurse ‘Navigates’ Her Father to Pain-Free Living
When Charlotte Davis’s dad complained about his back, the Hoag Spine Center nurse navigator knew two things: 1. The pain must be really bad for her active father to mention it and 2. Burak Ozgur, M.D., would be able to help. “We were at dinner, and I told her I was scared to death of … Read More
Published On: January 7, 2022
Pancreatic Cancer Clinical Trial Patient Partners with Hoag to Take Control of His Health
“I think about Jon every day,” Ruud said. “I feel lucky, in a way, to be part of this trial.” Not a day goes by that Olav Ruud doesn’t think about Jon Engen. Ruud befriended the three-time Olympian cross country racer years ago, bonding over their shared first language, Norwegian, and their love of … Read More
Published On: September 13, 2021